- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.
Cramer says he liked Yelp's quarter and is staying away from Cheniere Energy.
Cramer finds the good and the bad in the continued oil glut.
Pfizer (PFE) has agreed to acquire Medivation (MDVN) for $14 billion, fueling speculation of a future deal with Incyte (INCY).